Co-CEOs of Summit Therapeutics

The Co-CEOs of Summit Therapeutics, leaders in innovative biotech treatments, share exciting news about their new lung cancer drug showing promising results. They discuss its potential impact on patients and how it compares to current competitors. The podcast also dives into the persistent inflationary pressures, particularly in housing, and speculates on the Federal Reserve's response. Insights on market dynamics and the significance of recent economic data are also highlighted, making for a riveting discussion on the intersections of healthcare and finance.